LEAH DINGESS: Open Payments
NPI 1487308417 · LILBURN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,825 in 53 payments from 15 companies in 2025. Trend: 2023 $1,315 · 2024 $1,643 · 2025 $1,825
Food & beverage: $1,825
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $486 |
| Arcutis Biotherapeutics, Inc. | 5 | $259 |
| Organon LLC | 3 | $214 |
| GENZYME CORPORATION | 6 | $172 |
| Galderma Laboratories, L.P. | 4 | $152 |
| ABBVIE INC. | 4 | $92 |
| Novartis Pharmaceuticals Corporation | 3 | $92 |
| LEO Pharma Inc. | 3 | $80 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $68 |
| Biofrontera Inc. | 3 | $63 |
Products named: DUPIXENT, Zoryve, VTAMA, NEMLUVIO, LIBTAYO, ANZUPGO, SKYRIZI, RINVOQ.
Industry payments across GA — which companies pay providers there.
